Compounds > lipoxin a4

lipoxin a4 and Obesity

lipoxin a4 has been researched along with Obesity in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's8 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guo, YP; Jiang, H; Jiang, HK; Li, L; Tian, HY1
Gao, LL; Jiang, WW; Shen, DL; Wu, M; Zhao, T1
Ali-Shah, ST; Börgeson, E; Colas, RA; Dalli, J; Godson, C; Guiry, PJ; Johnson, AM; Lee, YS; Serhan, CN; Sharma, K; Syed, GH; Till, A1
Li, H; Lin, X; Pan, Q; Xu, Z; Yin, X; Yu, D; Zheng, F1
Agudo, J; Bosch, F; Casellas, A; Elias, I; Ferré, T; Franckhauser, S; Garcia, M; Molas, M; Muñoz, S; Roca, C; Ruberte, J; Vilà, L1
Birnbaum, GD; Birnbaum, I; Birnbaum, Y; Nylander, S; Ye, Y1
Börgeson, E; Corrigan, N; Godson, C; Harford, KA; Higgins, DF; Maderna, P; McGillicuddy, FC; Roche, HM1
Das, UN1

Reviews

1 review(s) available for lipoxin a4 and Obesity

ArticleYear
Arachidonic acid and lipoxin A4 as possible endogenous anti-diabetic molecules.
    Prostaglandins, leukotrienes, and essential fatty acids, 2013, Volume: 88, Issue:3

    Topics: Animals; Arachidonic Acid; Brain-Derived Neurotrophic Factor; Diabetes Mellitus; Fatty Acids, Unsaturated; Humans; Hypothalamus; Inflammation; Inflammation Mediators; Lipid Metabolism; Lipoxins; Obesity; Receptors, G-Protein-Coupled; Signal Transduction

2013

Other Studies

7 other study(ies) available for lipoxin a4 and Obesity

ArticleYear
Lipoxin A4 may attenuate the progression of obesity-related glomerulopathy by inhibiting NF-κB and ERK/p38 MAPK-dependent inflammation.
    Life sciences, 2018, Apr-01, Volume: 198

    Topics: Animals; Body Weight; Diet, High-Fat; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Extracellular Signal-Regulated MAP Kinases; I-kappa B Proteins; Inflammation; Injections, Intraperitoneal; Kidney Diseases; Kidney Glomerulus; Lipoxins; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; NF-kappa B; Obesity; p38 Mitogen-Activated Protein Kinases; Risk Factors

2018
[Effect of lipoxin A4 on the expression of Toll-like receptor 4 and TNF receptor-associated factor 6 in the liver of obese rats with sepsis].
    Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics, 2018, Volume: 20, Issue:7

    Topics: Animals; Humans; Interleukin-6; Lipoxins; Liver; Male; Obesity; Rats; Rats, Sprague-Dawley; Sepsis; Signal Transduction; TNF Receptor-Associated Factor 6; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha

2018
Lipoxin A4 Attenuates Obesity-Induced Adipose Inflammation and Associated Liver and Kidney Disease.
    Cell metabolism, 2015, Jul-07, Volume: 22, Issue:1

    Topics: Adipose Tissue; Animals; Anti-Inflammatory Agents, Non-Steroidal; Autophagy; Inflammation; Kidney; Kidney Diseases; Lipoxins; Liver; Liver Diseases; Mice, Inbred C57BL; Obesity

2015
Inverse Relationship between Serum Lipoxin A4 Level and the Risk of Metabolic Syndrome in a Middle-Aged Chinese Population.
    PloS one, 2015, Volume: 10, Issue:11

    Topics: Adiposity; Adult; Aged; Anti-Inflammatory Agents; Arachidonic Acid; Body Mass Index; China; Cross-Sectional Studies; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Humans; Incidence; Lipoxins; Male; Metabolic Syndrome; Middle Aged; Obesity; Prevalence; Prospective Studies; Regression Analysis; Risk Factors; Smoking

2015
ALOX5AP Overexpression in Adipose Tissue Leads to LXA4 Production and Protection Against Diet-Induced Obesity and Insulin Resistance.
    Diabetes, 2016, Volume: 65, Issue:8

    Topics: 5-Lipoxygenase-Activating Proteins; Adipose Tissue; Adipose Tissue, White; Animals; Diet, High-Fat; Gene Expression; Hep G2 Cells; Humans; Insulin Resistance; Leukotriene B4; Lipoxins; Mice; Mice, Transgenic; Obesity; Thermogenesis

2016
Ticagrelor and Rosuvastatin Have Additive Cardioprotective Effects via Adenosine.
    Cardiovascular drugs and therapy, 2016, Volume: 30, Issue:6

    Topics: Adenosine; Animals; Apoptosis Regulatory Proteins; CARD Signaling Adaptor Proteins; Cardiotonic Agents; Cyclooxygenase 2; Diabetes Mellitus, Experimental; Drug Synergism; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interleukin-1beta; Interleukin-6; Lipoxins; Male; Myocardial Reperfusion Injury; Myocardium; NLR Family, Pyrin Domain-Containing 3 Protein; Obesity; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Rats, Zucker; RNA, Messenger; Rosuvastatin Calcium; Ticagrelor

2016
Lipoxin A4 attenuates adipose inflammation.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2012, Volume: 26, Issue:10

    Topics: Adipose Tissue; Animals; Female; Glucose Transporter Type 4; Inflammation; Insulin Receptor Substrate Proteins; Insulin Resistance; Interleukin-10; Interleukin-6; Lipoxins; Mice; Mice, Inbred C57BL; Obesity; Tumor Necrosis Factor-alpha

2012